Abstract

Glioblastoma multiforme (GBM) requires radiotherapy (RT) as a part of definitive management strategy. RT is highly effective, destroying cancer cells that may exist around the surgical tumor bed. However, GBM still has a poor prognosis and a high local recurrence rate after RT. Accumulating research indicates that GBM contains cancer stem-like cells (CSCs), which are radioresistant and result in therapeutic failure. Additionally, GBM cells can aggressively invade normal brain tissue, inducing therapeutic failure. Using clinical observations, we evaluated the effect of radiation on tumor control. We also explored the biomolecular pathways that connect radioresistance and CSC- and epithelial-mesenchymal transition (EMT)-associated phenotypes in patient-derived GBM cells. Transwell and microarray assay demonstrated that radioresistant GBM cells (GBM-R2I2) exhibit increased invasion and self-renewal abilities compared with parental GBM cells. Finally, to identify potential mechanisms underlying these observations, we used a PCR array to search for molecular markers of cell motility. Signal transducer and activator of transcription 3 (STAT3) directly bound to the Slug promoter in a chromatin immunoprecipitation assay. Reduced STAT3 decreased Slug expression and suppressed cell invasion in GBM-R2I2 cells while increasing Slug reversed these effects. In addition, STAT3 knockdown significantly inhibited CSC properties, synergistically increased the radiotherapeutic effect, and effectively increased the survival rate in vivo. We deciphered a new pathway of GBM radioresistance, invasion, and recurrence via the STAT3/Slug axis that could be a new target of GBM therapy.

Highlights

  • Glioblastoma multiforme (GBM), malignant glioma of World Health Organisation (WHO) GradeIV [1], is the most devastating brain malignancy because it is resistant to all modern treatments, such as surgery radiotherapy (RT), chemotherapy, and immunotherapy [2]

  • We further explored whether the Signal transducer and activator of transcription 3 (STAT3)/Slug transcriptional axis mediated the tumor-initiating capability and cancer stem-like cells (CSCs) properties of GBM-R2I2 cells

  • Slug is an important factor in STAT3-dependent enhancement of radioresistance, motility, and CSC properties based on the following findings: (i) STAT3 directly bound to the Slug promoter; (ii) STAT3 upregulated Slug and contributed to tumor invasion, radioresistance, and CSC properties; (iii) the coexpression of STAT3 and Slug in GBM enhanced radioresistance and correlated with poor prognosis

Read more

Summary

Introduction

Glioblastoma multiforme (GBM), malignant glioma of World Health Organisation (WHO) GradeIV [1], is the most devastating brain malignancy because it is resistant to all modern treatments, such as surgery radiotherapy (RT), chemotherapy, and immunotherapy [2]. Cancers 2018, 10, 512 cells may be undetectable by such imaging These cells have the ability to regrow the primary tumor and promote recurrent disease [3]. Fractionated ionizing radiation (IR), which is similar in use to clinical RT, enhances the portion of the CSC population and migration of GBM cells in vivo [9,10]. It is still not understood whether the enhancement of such mechanisms is an inherent component of CSC adaptation and tumor motility in response to repeated radiation

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call